ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.78
+0.06 (0.89%)
Oct 10, 2025, 11:38 AM EDT - Market open
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $61.33 million as of October 10, 2025. Its market cap has increased by 121.81% in one year.
Market Cap
61.33M
Enterprise Value
69.05M
1-Year Change
121.81%
Ranking
Category
Stock Price
$6.78
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $61.33M, an increase of 2,978.86%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 60.79M | 32.45% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | 42.92M | 15.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.11B |
| Johnson & Johnson | 457.80B |
| AbbVie | 410.88B |
| UnitedHealth Group | 336.05B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 234.35B |